NCT03145714View on ClinicalTrials.gov

To Study the Effect of Sevoflurane and Propofol V Sevoflurane and Dexmedetomidine on Postoperative Cognitive Dysfunction

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

February 10, 2018

Study Completion Date

March 28, 2018

Conditions
Postoperative Cognitive Dysfunction
Interventions
DRUG

Maintainance of anesthesia with Intravenous Propofol infusion

The dosage of Intravenous Propofol will be titrated to maintain BIS Values between 40 -60.

DRUG

Maintainance of anesthesia with Intravenous Dexmedetomidine

The dosage of Intravenous Dexmedetomidine will be titrated to maintain BIS Values between 40 -60.

Trial Locations (2)

110078

Dr Anita Kulkarni, Delhi

110085

Rajiv Gandhi Cancer Institute and Research Centre, Delhi

All Listed Sponsors
lead

Rajiv Gandhi Cancer Institute & Research Center, India

OTHER

NCT03145714 - To Study the Effect of Sevoflurane and Propofol V Sevoflurane and Dexmedetomidine on Postoperative Cognitive Dysfunction | Biotech Hunter | Biotech Hunter